利用乙型肝炎病毒核心抗原的新型猪流行性腹泻病毒疫苗接种策略中表位选择及其放置位置以增强病毒中和
本研究对基于乙型肝炎病毒核心抗原(HBcAg)的重组疫苗策略进行设计修改,并在体内评价其效果。最初的多抗原候选疫苗能对插入嵌合蛋白的4个B细胞表位中的3个产生特异性抗体,但缺乏病毒中和能力,遂重新设计以重点激发针对PEDV的YSNIGVCK氨基酸基序的强免疫应答;基因修饰的新候选疫苗能对该表位产生强抗体应答,且与中和PEDV CO株能力增强相关,插入表位在载体蛋白中的位置也影响疫苗接种期间对天然HBcAg的免疫识别。
要点
- 最初多抗原候选疫苗可对4个B细胞表位中的3个产生特异性抗体,但缺乏病毒中和能力。
- 重新设计的疫苗重点激发针对PEDV YSNIGVCK基序的强抗体应答,并与中和CO株能力增强相关。
- 插入的PEDV表位在载体蛋白中的位置影响疫苗接种期间对天然HBcAg的免疫识别。
核心结论
- 基于HBcAg的重组疫苗策略经重新设计后,可对PEDV YSNIGVCK表位产生强抗体应答,并与中和CO株能力增强相关;插入表位的位置影响对天然HBcAg的免疫识别。
研究设计与样本
- 本研究为对基于HBcAg的重组疫苗策略进行设计修改并在体内评价其效果的实验研究。
主要发现
- 最初的多抗原候选疫苗能对插入嵌合蛋白的4个B细胞表位中的3个产生特异性抗体。
- 最初疫苗缺乏病毒中和能力,导致疫苗重新设计。
- 基因修饰的新候选疫苗能对YSNIGVCK表位产生强抗体应答,并与中和PEDV CO株能力增强相关。
- 插入的PEDV表位在载体蛋白中的位置影响疫苗接种期间对天然HBcAg的免疫识别。
关键数值与推荐
- 最初多抗原候选疫苗对4个B细胞表位中的3个产生特异性抗体。
- 新候选疫苗对YSNIGVCK表位产生强抗体应答,并与中和CO株能力增强相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Porcine epidemic diarrhea virus (PEDV) is a member of the Alphacoronaviridae genus within the Coronaviridae family. It is the causative agent of porcine epidemic diarrhea, a disease that can have mortality rates as high as 100% in suckling piglets. PEDV causes severe economic loss, and has been in existence for decades. A panzootic starting in 2010 renewed interest in the development of a universal vaccine toward PEDV. This report details several design changes made to a Hepatitis B virus core antigen (HBcAg)-based recombinant vaccine strategy, and their effect in vivo. Initially, several multi-antigen vaccine candidates were able to elicit antibodies specific to three out of four B-cell epitopes inserted into the chimeric proteins. However, a lack of virus neutralization led to a redesign of the vaccines. The focus of the newly redesigned vaccines was to elicit a strong immune response to the YSNIGVCK amino acid motif from PEDV. Genetically modified new vaccine candidates were able to elicit a strong antibody (Ab) response to the YSNIGVCK epitope, which correlated with an increased ability to neutralize the CO strain of PEDV. Additionally, the location of the inserted PEDV epitopes within the vector protein was shown to affect the immune recognition toward the native HBcAg during vaccination.
引用
- Gillam F, Zhang C. Epitope selection and their placement for increased virus neutralization in a novel vaccination strategy for porcine epidemic diarrhea virus utilizing the Hepatitis B virus core antigen. Vaccine. 2018. PMID: 29914846. doi:10.1016/j.vaccine.2018.06.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。